[PRESS RELEASE] – CHICAGO, April 30, 2026 – Verano Holdings Corp., a leading multistate cannabis company, announced that its board of directors has authorized the repurchase of up to $20 million in shares of the company’s common stock, which are listed for trading on Cboe Canada.
“Given business performance and the transformative Schedule III medical cannabis designation, we believe the share repurchase authorization provides Verano further optionality to deploy capital in pursuit of growth initiatives,” Verano Chairman and CEO George Archos said. “The share repurchase authorization offers Verano another strategic outlet to unlock value for the company and our shareholders, including strengthening the balance sheet and accretive M&A opportunities.”
The Normal Course Issuer Bid (NCIB) will be executed in accordance with the applicable rules and policies of Cboe Canada and U.S. and Canadian securities laws. Pursuant to the NCIB, Verano may purchase up to an aggregate of 18,219,090 shares (representing 5% of the issued and outstanding shares of the company at the time of the authorization), subject to the $20 million limit. The purchases may be made from time to time over a period of 12 months ending April 30, 2027, unless such share or dollar limit is met sooner.
On any given day, Verano may not purchase more than 25% of the average daily trading volume of its shares and is subject to other limitations set forth by Cboe Canada and Rule 10b-18 under the Securities Exchange Act of 1934 (the “Exchange Act”). In addition, Verano may make block purchases of shares that meet certain criteria and sales may be made through open-market repurchases, privately negotiated transactions or otherwise.
All purchases made will be through the selected purchasing member, ATB Capital Markets Corp., through the facilities of Cboe Canada or through alternative trading systems. The actual number of shares which will be purchased, the timing of such purchases, and the price at which the shares will be purchased by Verano will be aligned with the rules and policies of the Cboe Canada Listing Manual and with U.S. securities regulations, including Rule 10b-18 under the Exchange Act. No assurance can be given that any particular number of shares will be repurchased.
In determining the amount of capital to allocate to share repurchases, the company takes into account, among other things, its historical and expected business performance and cash and liquidity position, as well as global economic and market conditions and the market price of the shares. The timing, manner, price and amount of any repurchases under the share repurchase program are determined by the company in its discretion. Purchases may be effected through open market transactions, privately negotiated transactions, transactions structured through investment banking institutions or other means. The company is not obligated to repurchase any specific number of shares and the program may be modified, suspended or discontinued at any time.
